business

Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)

Yahoo Finance · May 22, 2026, 6:43 PM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Citi sees AI price effects as key issue for Warsh Investing.com Fair Isaac stock price target held at $2,400 by RBC Capital

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX)

Also covered by

More in business